Stifel Nicolaus Issues Positive Forecast for AtriCure (NASDAQ:ATRC) Stock Price
AtriCure (NASDAQ:ATRC – Get Free Report) had its price target upped by stock analysts at Stifel Nicolaus from $36.00 to $48.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. Stifel Nicolaus’ price target would suggest a potential upside of 17.24% from the company’s […]
AtriCure (NASDAQ:ATRC – Get Free Report) had its price target upped by stock analysts at Stifel Nicolaus from $36.00 to $48.00 in a report released on Thursday,Benzinga reports. The firm currently has a “buy” rating on the medical device company’s stock. Stifel Nicolaus’ price target would suggest a potential upside of 17.24% from the company’s […]
